WGWojciech Gąska

Wojciech Gąska

*This is an algorithmically generated author record based on publicly available information.

Wojciech Gąska has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    MODERN STRATEGIES FOR THE TREATMENT OF TREATMENT-RESISTANT DEPRESSION – A LITERATURE REVIEW

    by Ignacy Rożek, Wojciech Gąska, Izabela Lekan, Joanna Mazurek, Agnieszka Brzezińska, Weronika Tuszyńska, Alicja Sodolska, Michał Lenart, Barbara Madoń, Barbara Teresińska

    Treatment-resistant depression (TRD) remains a major therapeutic challenge in psychiatry, affecting a substantial proportion of individuals diagnosed with major depressive disorder and contributing significantly to the overall burden of mental illness. Despite decades of research and the availability of numerous antidepressant agents, many patients fail to achieve full remission, which underscores the urgent need for more effective interventions. This review provides a comprehensive and up-to-date analysis of both established and novel strategies for the management of TRD, encompassing pharmacological augmentation approaches, a variety of neuromodulation techniques, the clinical application of psychedelic- assisted therapies, and the development of innovative compounds currently under investigation. Particular emphasis is placed on the therapeutic potential and clinical outcomes associated with ketamine, esketamine, and psilocybin, which have emerged as promising options for patients who do not respond to conventional treatments. In addition, the review explores future directions in TRD management, including the repurposing of agents such as lurasidone, pioglitazone, and minocycline, which may offer new mechanisms of action and improved tolerability. Finally, the discussion highlights the importance of adopting a personalized, evidence-based, and multidimensional treatment approach, with the goal of improving both short-term response rates and long-term functional recovery in individuals suffering from TRD.

  • Open Access

    ADHD TREATMENT: FROM MEDICATION TO BEHAVIORAL THERAPIES- A SYSTEMATIC REVIEW

    by Barbara Madoń, Agnieszka Brzezińska, Maciej Dudziński, Wojciech Gąska, Izabela Lekan, Michał Lenart, Joanna Mazurek, Ignacy Rożek, Barbara Teresińska, Weronika Tuszyńska

    Introduction: Nowadays, ADHD is one of the most common diagnoses in the mental health field. It presents a wide spectrum of clinical presentations that affect patients’ everyday life. Variety of symptoms make each patients’ needs individual, and because of that, treatment of ADHD must be adjusted to each person separately to achieve the best possible outcome. Materials and methods: This article, based on a PubMed review of available research, examines ADHD treatment Key findings and conclusions: Options in first line medications are limited, therefore formulation technologies are one of the few methods to modify the therapy. Alternative to that, especially for patients that cannot take stimulants, are non-stimulant medications generally used in other medical fields. Additionally, psychotherapy is inherent for patients to understand their disorder, which allows them to accept it. The aim of this article is to present the basis of a complex issue, as ADHD treatment is.

  • Open Access

    CUTANEOUS MELANOMA – DIAGNOSIS, TREATMENT, AND THE POTENTIAL IMPACT OF PHYSICAL ACTIVITY

    by Izabela Lekan, Michał Lenart, Wojciech Gąska, Ignacy Rożek, Joanna Mazurek, Agnieszka Brzezińska, Weronika Tuszyńska, Alicja Sodolska, Barbara Madoń, Barbara Teresińska

    Malignant melanoma is one of the most aggressive forms of skin cancer, with its incidence steadily increasing worldwide. Although it accounts for a minority of skin cancer cases, it is responsible for the majority of skin cancer–related deaths. This review discusses the epidemiology, clinical characteristics, and histopathological features of the main melanoma subtypes, including superficial spreading melanoma (SSM), nodular melanoma (NM), lentigo maligna melanoma (LMM), and acral lentiginous melanoma (ALM). Particular attention is given to current diagnostic strategies, ranging from the gold standard of histopathological examination to emerging non-invasive techniques such as dermoscopy, reflectance confocal microscopy (RCM), optical coherence tomography (OCT), high-frequency ultrasound (HFUS), and the novel tape stripping method. These approaches have improved early detection and the accurate assessment of tumor margins, supporting more personalized therapeutic planning. Treatment remains primarily surgical in early-stage melanoma, while advanced cases increasingly benefit from immunotherapy and targeted therapies, which have significantly improved survival outcomes. Additionally, this article explores the potential association between physical activity and melanoma risk, emphasizing that outdoor activity may increase susceptibility due to greater ultraviolet (UV) exposure. Prevention strategies, including public education and effective photoprotection, remain essential in mitigating disease burden. In conclusion, despite significant advances in diagnosis and therapy, malignant melanoma continues to pose major clinical and public health challenges, underscoring the importance of early detection, prevention, and ongoing research.

  • Open Access

    MULTIDIMENSIONAL TREATMENT OF ENDOMETRIOSIS – THE ROLE OF NUTRITIONAL, PHYSIOTHERAPEUTIC AND PSYCHOLOGICAL INTERVENTIONS

    by Barbara Teresińska, Michał Lenart, Wojciech Gąska, Ignacy Rożek, Izabela Lekan, Joanna Mazurek, Agnieszka Brzezińska, Weronika Tuszyńska, Alicja Sodolska, Barbara Madoń

    Endometriosis is a chronic, progressive gynecological disease characterized by the presence of active endometrial tissue outside the uterine cavity. Endometriosis impacts around 10% of women in their reproductive years, often leading to persistent pain, cycle disturbances, and challenges with conception. Conventional management, which includes medication and surgery, is often insufficient due to high recurrence rates and suboptimal outcomes, prompting increased focus on complementary treatment strategies. The main aim of this work is to analyze the role of three key areas of supportive therapy: diet, physiotherapy and psychotherapy in relieving the symptoms of endometriosis and improving the quality of life of patients. This is a review-based study that analyzes scientific sources from 1997 to 2025. Analysis of current studies highlights the potential of an anti-inflammatory diet, regular pelvic-focused physiotherapy, and psychotherapy as effective complementary strategies alongside conventional treatment. An integrated therapeutic approach, taking into account the somatic and psychological needs of patients, seems to be crucial in the effective management of endometriosis.

  • Open Access

    DEMENTIA – DIFFERENTIATION AND THE SIGNIFICANCE OF EARLY DIAGNOSIS

    by Joanna Mazurek, Wojciech Gąska, Ignacy Rożek, Izabela Lekan, Agnieszka Brzezińska, Weronika Tuszyńska, Alicja Sodolska, Michał Lenart, Barbara Madoń, Barbara Teresińska

    Dementias are a complex group of neurodegenerative diseases characterized by a progressive decline in cognitive functions, significantly affecting patients' daily lives. Differentiating between types of dementia, such as Alzheimer’s disease, vascular dementia, Lewy body dementia, and frontotemporal dementia, is essential for appropriate therapy planning, disease prognosis, and optimizing care. Diagnosis is based on a comprehensive assessment of clinical symptoms, neuroimaging studies, and analysis of fluid biomarkers. Clinical symptoms, such as memory impairment, attention deficits, executive dysfunction, and behavioral changes, are the basis of diagnosis; however, differentiation requires support from brain imaging techniques such as magnetic resonance imaging (MRI) and positron emission tomography (PET), which allow the identification of characteristic structural and metabolic changes. Biomarkers, particularly tau and beta-amyloid proteins measured in cerebrospinal fluid and serum, are important tools for confirming the diagnosis and monitoring disease progression. Early diagnosis of dementia is crucial for the effectiveness of therapy and improving patients’ quality of life. It enables the implementation of interventions that slow disease progression and provides appropriate psychosocial support for patients and their families. In recent years, artificial intelligence (AI) has played an increasing role in the diagnosis of dementia. Advanced algorithms analyzing clinical, neuroimaging, and biomarker data support more accurate and faster differentiation of dementia types and help identify at-risk individuals at early disease stages. The implementation of AI in clinical practice opens new opportunities for personalized treatment and patient care.

  • Open Access

    THE CORRELATION BETWEEN SLEEP DISORDERS AND ULCERATIVE COLITIS AND OTHER AUTOIMMUNE DISEASES: A SCIENTIFIC REVIEW

    by Agnieszka Brzezińska, Wojciech Gąska, Ignacy Rożek, Izabela Lekan, Joanna Mazurek, Weronika Tuszyńska, Alicja Sodolska, Michał Lenart, Barbara Madoń, Barbara Teresińska

    Ulcerative colitis (UC), a chronic inflammatory bowel disease (IBD), is an autoimmune disease and is increasingly recognised for its bidirectional relationship with sleep disorders. Emerging evidence suggests that sleep disturbances not only exacerbate UC symptoms but may also influence disease activity and relapse rates. Sleep deprivation is increasingly recognized as a significant factor influencing the pathogenesis and progression of autoimmune diseases. This review also synthesizes current evidence on the bidirectional relationship between sleep disturbances and autoimmune conditions, focusing on underlying mechanisms, clinical implications, and potential therapeutic strategies.

  • Open Access

    KETAMINE AS AN OPTIONAL TREATMENT IN CHRONIC PAIN - A REVIEW

    by Mathias Spitaleri, Karol Kanon, Filip Kieloch, Julia Głowacka, Agnieszka Fitas, Wojciech Gąska, Karolina Dębek-Kalinowska, Oskar Sienkiel, Wiktor Gąska, Dawid Sewruk

    Chronic pain is a pervasive and debilitating condition that affects millions of individuals worldwide. Traditional methods of pain management, including the use of opioids, often fall short in providing adequate relief and come with significant risks, such as dependency and tolerance. As a result, there has been growing interest in exploring alternative treatments, with ketamine emerging as a promising option. Ketamine, a dissociative anesthetic, has shown potential in alleviating various types of chronic pain, including neuropathic pain, cancer-related pain, and pain associated with complex regional pain syndrome (CRPS). Aim of study: This review aims to examine the current evidence on the efficacy of ketamine in chronic pain management, exploring its mechanisms of action, clinical applications, safety profile, and potential limitations. Methods and materials: PubMed and Scopus databases were used to search for topic treated articles.

  • Open Access

    COMPREHENSIVE REVIEW OF TREATMENT OPTIONS FOR ERECTILE DYSFUNCTION: MODERN AND TRADITIONAL METHODS

    by Oskar Sienkiel, Agnieszka Fitas, Wojciech Gąska, Julia Głowacka, Mathias Spitaleri, Filip Kieloch, Dawid Sewruk, Wiktor Gąska, Karol Kanon, Karolina Dębek-Kalinowska

    Introduction: Erectile dysfunction (ED), or impotence, is a condition where a man can't get or keep an erection firm enough for satisfying sexual intercourse. It affects men of all ages and is caused by a variety of physical, psychological, or social factors. The number of ED cases is growing annually, and treatment costs are rising steadily. This combination of increasing prevalence and rising expenses highlights the need for a highly optimized treatment method. Efforts should focus on finding a solution that is as effective as possible while also being cost-efficient. The goal is to provide accessible, high-quality care without the financial burden, ensuring that men who suffer from this condition can find relief and improve their quality of life. The search for such a method is crucial given the growing impact of ED on men worldwide. Aim: The aim of this study was to review literature studies on ED and methods for treating this condition. Method: Data for the article were retrieved by using Pub Med setting the time descriptor to 2020-2025. Conclusions: Despite the availability of many effective treatments for erectile dysfunction (ED), it can still be a challenging condition due to the variety of underlying causes. Therefore, an individualized approach and thorough diagnostics are essential. Regenerative therapies and shockwave therapy, although still experimental, offer new therapeutic opportunities. In the future, it will be important to conduct randomized studies with long-term follow-up to assess the effectiveness and safety of these new methods.

  • Open Access

    AGENESIS OF THE INTERNAL CAROTID ARTERY - COLLATERAL VASCULARIZATION AND SYMPTOMATIC MANIFESTATIONS

    by Hubert Stachowicz, Karolina Paterek, Aleksandra Makarewicz, Aleksandra Pacek, Joanna Mazurek, Wojciech Gąska, Maciej Samczuk

    Introduction and objective: Internal carotid artery agenesis is a rare anatomical anomaly involving the absence of the internal carotid artery. It is a congenital developmental defect that can present with varying symptoms depending on whether it is unilateral or bilateral. The aim of this article is to summarize the diversity and prevalence of symptoms associated with unilateral or bilateral agenesis of the internal carotid artery. Methodology: In the literature review, scientific works related to internal carotid artery agenesis were utilized, including 26 studies addressing the described variability, which collectively encompass 52 cases of patients with internal carotid artery agenesis. After a thorough analysis of the cited literature, conclusions were drawn regarding the frequency and relationships between unilateral and bilateral absence of the ICA. Discussion: Agenesis of the internal carotid artery is a rare anomaly; however, its detection is crucial in the diagnosis of cerebrovascular disorders. Among symptomatic patients with internal carotid artery agenesis, intracranial aneurysms leading to subarachnoid hemorrhages were frequently observed. Additionally, collateral pathways replacing its blood flow, such as perineural anastomoses, and alterations in the normal course of other vessels in the neck and head region were also noted. Conclusions: Agenesis of the ICA occurs in 0.01% of cases and is additionally associated with the absence of the carotid canal, through which the artery typically traverses. It is more commonly seen as left-sided agenesis of the ICA, with bilateral agenesis occurring in less than 10% of cases. 25% of cases of internal carotid artery agenesis are associated with intracranial aneurysms. The majority of symptomatic patients are between 35 and 65 years of age. Patients with internal carotid artery agenesis most frequently exhibit neurological disorders as well as nonspecific symptoms such as headaches and nausea.

  • Open Access

    OBESITY MANAGEMENT - A COMPARATIVE REVIEW OF THE EFFICACY AND SAFETY OF BARIATRIC SURGERY AND TIRZEPATIDE THERAPY

    by Wojciech Gąska, Ignacy Rożek, Izabela Lekan, Joanna Mazurek, Agnieszka Brzezińska, Weronika Tuszyńska, Alicja Sodolska, Michał Lenart, Barbara Madoń, Barbara Teresińska

    Objective: Obesity is a major global health burden associated with increased morbidity, mortality, and healthcare costs. This review aimed to compare the efficacy and safety of tirzepatide, a novel dual GLP-1/GIP receptor agonist, with bariatric surgery, focusing on their roles in weight reduction, metabolic improvement, and long-term risk–benefit profiles. Methods: A comprehensive literature search was performed using PubMed and official regulatory and professional society sources (FDA, EMA, MHRA, IFSO). Search terms included “obesity,” “bariatric surgery,” “tirzepatide,” and “GLP-1 and GIP receptor agonist.” Only peer-reviewed English-language studies with high levels of evidence, including randomized controlled trials, meta-analyses, systematic reviews, and clinical guidelines, were included. Key Findings: Bariatric surgery, particularly Roux-en-Y gastric bypass and sleeve gastrectomy, was associated with the most profound and durable weight loss (25–28% short-term; 18–25% long-term), alongside significant remission of type 2 diabetes, hypertension, and dyslipidemia. However, its invasive nature and risk of perioperative and late complications necessitate multidisciplinary follow-up. Tirzepatide demonstrated dose-dependent reductions in body weight (~10–20%), improved glycemic control, lipid profiles, and blood pressure, and enhanced quality of life. Its safety profile was favorable, predominantly gastrointestinal, but long-term data remain limited. Conclusions: Bariatric surgery remains the gold standard for severe obesity due to its magnitude and sustainability of benefits. Tirzepatide represents a promising, less-invasive pharmacological option, particularly for patients with moderate obesity or contraindications to surgery. Further research is required to establish its long-term efficacy and safety profile.